Why Neuromodulation Devices Face Great Promise – and Challenges – for Growth in EMEA Markets
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Why Neuromodulation Devices Face Great Promise – and Challenges – for Growth in EMEA Markets
-
ナレーター：
-
著者：
このコンテンツについて
In this episode of the DeviceTalks Weekly Podcast, Vincent Sourdaine, vice president of neuromodulation for EMEA, shares his journey into the MedTech industry and his fascination with neurotechnologies.
Overseeing product launches in over 100 countries, he discusses the deep need for pain relief and other benefits of neuromodulation, and the challenges presented by EMEA’s unique health care markets.
This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.DeviceTalks.com to register. Use the discount code mentioned in the episode.
But we’ll start off the episode with MassDevice Editor Chris Newmarker’s #NewmarkersNewsmakers including Cardinal Health, AdvaMed, Zimmer Biomet, EndoGenex, HistoSonics, and orthopedic companies.
Go to MassDevice.com for our medical device coverage.
Thank you for listening to this episode of the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.